Iosif Strouthos
Overview
Explore the profile of Iosif Strouthos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Koerber S, et al.
Radiother Oncol
. 2024 Mar;
194:110215.
PMID: 38458259
Purpose: The European Association of Urology (EAU) proposed a risk stratification (high vs. low risk) for patients with biochemical recurrence (BR) following radical prostatectomy (RP). Here we investigated whether this...
12.
Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, et al.
Eur J Nucl Med Mol Imaging
. 2023 Sep;
51(2):558-567.
PMID: 37736808
Aim: The optimal management for early recurrent prostate cancer following radical prostatectomy (RP) in patients with negative prostate-specific membrane antigen positron-emission tomography (PSMA-PET) scan is an ongoing subject of debate....
13.
Doolan P, Charalambous S, Roussakis Y, Leczynski A, Peratikou M, Benjamin M, et al.
Front Oncol
. 2023 Aug;
13:1213068.
PMID: 37601695
Purpose/objectives: Auto-segmentation with artificial intelligence (AI) offers an opportunity to reduce inter- and intra-observer variability in contouring, to improve the quality of contours, as well as to reduce the time...
14.
Zamboglou C, Peeken J, Janbain A, Katsahian S, Strouthos I, Ferentinos K, et al.
JAMA Netw Open
. 2023 May;
6(5):e2314748.
PMID: 37219907
Importance: Prostate-specific antigen membrane positron-emission tomography (PSMA-PET) is increasingly used to guide salvage radiotherapy (sRT) after radical prostatectomy for patients with recurrent or persistent prostate cancer. Objective: To develop and...
15.
Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Lanzafame H, et al.
Radiother Oncol
. 2023 May;
184:109678.
PMID: 37146766
Background/purpose: The present study aimed to assess whether SRT to the prostatic fossa should be initiated in a timely manner after detecting biochemical recurrence (BR) in patients with prostate cancer,...
16.
Nikulin P, Zschaeck S, Maus J, Cegla P, Lombardo E, Furth C, et al.
Eur J Nucl Med Mol Imaging
. 2023 Apr;
50(9):2751-2766.
PMID: 37079128
Purpose: PET-derived metabolic tumor volume (MTV) and total lesion glycolysis of the primary tumor are known to be prognostic of clinical outcome in head and neck cancer (HNC). Including evaluation...
17.
Solomonidou N, Germanou D, Strouthos I, Karagiannis E, Farolfi A, Koerber S, et al.
Eur J Nucl Med Mol Imaging
. 2023 Mar;
50(8):2529-2536.
PMID: 36905411
Purpose: The purpose of this retrospective, multicenter study was to assess efficacy of PSMA-PET/CT-guided salvage radiotherapy (sRT) in patients with recurrent or persistent PSA after primary surgery and PSA levels ...
18.
Zschaeck S, Weingartner J, Lombardo E, Marschner S, Hajiyianni M, Beck M, et al.
Front Oncol
. 2022 Jun;
12:870319.
PMID: 35756665
Purpose: 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is utilized for staging and treatment planning of head and neck squamous cell carcinomas (HNSCC). Some older publications on the prognostic relevance showed inconclusive...
19.
Zamboglou C, Strouthos I, Sahlmann J, Farolfi A, Serani F, Medici F, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
113(5):1015-1024.
PMID: 35659629
Purpose: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is increasingly used to guide salvage radiation therapy (sRT) in patients with prostate cancer and biochemical recurrence/persistence after prostatectomy. This work examined...
20.
Karagiannis E, Strouthos I, Leczynski A, Zamboglou N, Ferentinos K
Front Oncol
. 2022 Mar;
12:800920.
PMID: 35299745
The optimal management of intrahepatic malignancies involves a multidisciplinary approach. Although surgical resection has been considered the only curative approach, the use of several minimally invasive ablative techniques has dramatically...